Press Releases News / Events Overview Press Releases In The News IR Calendar Email Alerts NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16th Sep 09, 2019 8:39am EDT NeuBase Therapeutics Reports Financial Results for the Fiscal Third Quarter of 2019 Aug 14, 2019 4:05pm EDT NeuBase Therapeutics to Ring the NASDAQ Closing Bell Today Aug 07, 2019 8:00am EDT NeuBase Therapeutics Announces Addition of Industry Pioneer Dr. Samuel Broder and World-Renowned Geneticist Dr. George Church to Scientific Advisory Board Jul 30, 2019 8:00am EDT NeuBase Therapeutics Appoints Danith Ly, Ph.D. as Chief Scientific Officer Jul 24, 2019 8:00am EDT NeuBase Therapeutics Initiates Trading on NASDAQ Under Ticker Symbol “NBSE” Jul 15, 2019 10:20am EDT NeuBase Therapeutics Closes Merger Transaction with Ohr Pharmaceutical Jul 12, 2019 9:28am EDT NeuBase Therapeutics to Participate in Roth RNA Revolution Conference Jul 11, 2019 8:00am EDT NeuBase Therapeutics to Present at the LD Micro Conference Jun 05, 2019 9:55am EDT NeuBase Therapeutics Designates Industry Leaders to Board of Directors May 16, 2019 8:00am EDT 1 2 Next
NeuBase Therapeutics Hosting Key Opinion Leader Meeting on Huntington's Disease and PATrOL™-Enabled Therapy on September 16th Sep 09, 2019 8:39am EDT
NeuBase Therapeutics Reports Financial Results for the Fiscal Third Quarter of 2019 Aug 14, 2019 4:05pm EDT
NeuBase Therapeutics Announces Addition of Industry Pioneer Dr. Samuel Broder and World-Renowned Geneticist Dr. George Church to Scientific Advisory Board Jul 30, 2019 8:00am EDT
